Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Epidemiology and Health Care Burden of Alcohol Use DisorderEpidemiology of Alcohol-Associated Liver Disease Including Increasing Burden in Young Adults and Females Especially Since COVID-19 Pandemic
Alcohol and Metabolic Syndrome Interaction
Alcohol-Associated Liver Diseases: Spectrum, Nomenclature, and Definitions
Alcohol and Hepatocellular Carcinoma
Pathogenesis of Alcohol-Associated Liver Disease
Gut Bacteria in Alcohol-Associated Liver Disease
Beyond the Liver: Neurologic Manifestations of Alcohol Use
Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease
Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease
Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis: Current Status and Future Landscape
Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies
Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease
Integrated Multidisciplinary Care Model to Manage the Dual Pathology of Alcohol Use Disorder and of Liver Disease
Liver Transplantation in Alcohol-Associated Liver Disease: Current Status and Future Landscape
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease
Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease
Authors
Ashwani K. Singal Professor of Medicine University of South Dakota, Sanford SOMTransplant Hepatologist Avera Transplant Institute
Research Scientist VA Medical Center
Sioux Falls, SD, USA.

